Joseph Horrigan Joins AMO Pharma as Chief Medical Officer

Company further expands leadership team with new VP of Clinical Operations and Head of Pharmaceutical Science and Manufacturing LONDON and PHILADELPHIA, April 18, 2016 -- (Healthcare Sales & Marketing Network) -- AMO Pharma Limited ("AMO Pharma&qu... Biopharmaceuticals, PersonnelAMO Pharma, fragile X syndrome, myotonic dystrophy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news